We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Short Communication

Monocyte to high-density lipoprotein cholesterol ratio as highly predictive marker in patients with acute coronary syndrome

    Kevin Karim

    *Author for correspondence:

    E-mail Address: kevinkarim.official@gmail.com

    Department of Cardiology & Vascular Medicine, Dustira Army Hospital, Cimahi, Indonesia

    ,
    Mohammad Sidqi Aulia

    Department of Cardiology & Vascular Medicine, Dustira Army Hospital, Cimahi, Indonesia

    ,
    Irfan Surya Pradisa

    Department of Cardiology & Vascular Medicine, Dustira Army Hospital, Cimahi, Indonesia

    ,
    Moch Fatichul Huda

    Department of Cardiology & Vascular Medicine, Dustira Army Hospital, Cimahi, Indonesia

    ,
    Arinta Setyasari

    Department of Cardiology & Vascular Medicine, Dustira Army Hospital, Cimahi, Indonesia

    ,
    Sherly Yosephina

    Department of Cardiology & Vascular Medicine, Dustira Army Hospital, Cimahi, Indonesia

    &
    Nizamuddin Ubaidillah

    Department of Cardiology & Vascular Medicine, Dustira Army Hospital, Cimahi, Indonesia

    Published Online:https://doi.org/10.2217/fca-2023-0001

    Aim: This study examined the relationship between Thrombolysis in Myocardial Infarction (TIMI) score and monocyte to high-density lipoprotein cholesterol (HDL-C) ratio (MHR) with Global Registry of Acute Coronary Events (GRACE) in patients with acute coronary syndrome (ACS). Materials & methods: A total of 1000 patients with ACS admitted to the Cardiology Department of the Dustira Army Hospital were included in this study. Medical records were retrospectively reviewed from January 2019 to June 2020 with consecutive sampling. Results: In the group with a higher TIMI score, the MHR result was considerably higher. In the same way, MHR was more significant in the group with a high-risk than in low-risk GRACE. Conclusion: MHR is a convenient, reproducible and correlates with GRACE and TIMI score as predictive biomarkers in patients with ACS.

    Papers of special note have been highlighted as: • of interest

    References

    • 1. Mc Namara K, Alzubaidi H, Jackson JK. Cardiovascular disease as a leading cause of death: how are pharmacists getting involved? Integr. Pharm. Res. Pract. 8, 1–11 (2019).
    • 2. Roth GA, Huffman MD, Moran AE et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 132(17), 1667–1678 (2015).
    • 3. Singh A, Museedi AS, Grossman SA. Acute Coronary Syndrome. StatPearls Publishing LLC, FL, USA (2022). www.ncbi.nlm.nih.gov/books/NBK459157/
    • 4. Domienik-Karłowicz J, Kupczyńska K, Michalski B et al. Fourth universal definition of myocardial infarction. Selected messages from the European Society of Cardiology document and lessons learned from the new guidelines on ST-segment elevation myocardial infarction and non-ST-segment elevation-acute coronary syndrome. Cardiol. J. 28(2), 195–201 (2021).
    • 5. Rampenga SH. Kegawatdaruratan Jantung. Badan Penerbit Fakultas Kedokteran Universitas Indonesia, Jakarta, Indonesia ISBN: 978-979-496-875-8 3–5 (2015).
    • 6. Tanaka S, Couret D, Tran-Dinh A et al. High-density lipoproteins during sepsis: from bench to bedside. Crit. Care 24(1), 134 (2020).
    • 7. Murphy AJ, Westerterp M, Yvan-Charvet L, Tall AR. Anti-atherogenic mechanisms of high-density lipoprotein: effects on myeloid cells. Biochim. Biophys. Acta 1821(3), 513–521 (2012).
    • 8. Villanueva DLE, Tiongson MD, Ramos JD, Llanes EJ. Monocyte to high-density lipoprotein ratio (MHR) as a predictor of mortality and major adverse cardiovascular events (MACE) among ST elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis. Lipids Health Dis. 19(1), 55 (2020).
    • 9. Sercelik A, Besnili AF. Increased monocyte to high-density lipoprotein cholesterol ratio is associated with TIMI risk score in patients with ST-segment elevation myocardial infarction. Rev. Port. Cardiol. 37(3), 217–223 (2018). • This paper was interesting as it shows the correlation between monocyte to HDL-C ratio (MHR) and Thrombolysis in Myocardial Infarction scores in ST-elevation myocardial infarction (STEMI) patients. This paper also found a new important finding: MHR is considerably used as a predictor in short-term cardiovascular events and STEMI patients.
    • 10. Rao SS, Agasthi P. ‘Thrombolysis in myocardial infarction risk score’. StatPearls. StatPearls Publishing, FL, USA (2023). www.ncbi.nlm.nih.gov/books/NBK556069/
    • 11. Chan Pin Yin D, Azzahhafi J, James S. Risk assessment using risk scores in patients with acute coronary syndrome. J. Clin. Med. 9(9), 3039 (2020).
    • 12. Cetin MS, Ozcan Cetin EH, Kalender E et al. Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome. Heart Lung Circ. 25(11), 1077–1086 (2016).
    • 13. Çağdaş M, Karakoyun S, Yesin M et al. The association between monocyte HDL-C ratio and SYNTAX score and SYNTAX score II in STEMI patients treated with primary PCI. Acta Cardiol. Sin. 34(1), 23–30 (2018).
    • 14. Balta S, Celik T, Ozturk C et al. The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction. Am. J. Emerg. Med. 34(8), 1542–1547 (2016).
    • 15. Zhao G, Cui C, Li M. Relationship between monocyte to high-density lipoprotein cholesterol ratio and the thrombolysis in myocardial infarction risk score in elderly patients with ST-segment elevation myocardial infarction. Chinese J. Geriatr. 12, 1097–1101 (2021).
    • 16. Yılmaz M, Kayançiçek H. A new inflammatory marker: elevated monocyte to HDL cholesterol ratio associated with smoking. J. Clin. Med. 7(4), 76 (2018).
    • 17. Acikgoz N, Kurtoğlu E, Yagmur J, Kapicioglu Y, Cansel M, Ermis N. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Behçet disease. Angiology 69(1), 65–70 (2018).
    • 18. Karataş MB, Çanga Y, Özcan KS et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am. J. Emerg. Med. 34(2), 240–244 (2016). • This paper was interesting as it shows the relationship between MHR, in-hospital MACA and mortality in STEMI patients. It is found that higher admission preprocedural MHR is an independent predictor of in-hospital mortality and MACE.
    • 19. Ganjali S, Gotto AM, Ruscica M et al. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J. Cell. Physiol. 233(12), 9237–9246 (2018).
    • 20. Huang J-B, Chen Y-S, Ji H-Y et al. Neutrophil to high-density lipoprotein ratio has a superior prognostic value in elderly patients with acute myocardial infarction: a comparison study. Lipids Health Dis. 19(1), 59 (2020). • This paper was interesting as it compares the neutrophil to HDL-C ratio (NHR) to other prognostic indices, such as the MHR and the LDL-C to HDL-C ratio (LDL-C/HDL-C) in elderly acute myocardial infarction patients. The findings demonstrates that a higher level of NHR was linked to a higher risk of RMI and long-term mortality. Compared with MHR and LDL-C/HDL-C, NHR has a better predictive value for long-term clinical outcomes in older people.
    • 21. Gandhi SJ, Hagans I, Nathan K, Hunter K, Roy S. Prevalence, comorbidity and investigation of anemia in the primary care office. J. Clin. Med. Res. 9(12), 970–980 (2017).
    • 22. Hlaing HH, Liabsuetrakul T. Dietary intake, food pattern, and abnormal blood glucose status of middle-aged adults: a cross-sectional community-based study in Myanmar. Food Nutr. Res. 60(1), 28898 (2016).
    • 23. Shahangian S, Snyder SR. Laboratory medicine quality indicators. Am. J. Clin. Pathol. 131(3), 418–431 (2009).
    • 24. Acet H, Ertaş F, Akil MA et al. Relationship between hematologic indices and global registry of acute coronary events risk score in patients with ST-segment elevation myocardial infarction. Clin. Appl. Thromb. 22(1), 60–68 (2016).
    • 25. Enhos A, Cosansu K, Huyut MA et al. Assessment of the relationship between monocyte to high-density lipoprotein ratio and myocardial bridge. Arq. Bras. Cardiol. 112(1), 12–17 (2019).
    • 26. Pollack CV, Sites FD, Shofer FS, Sease KL, Hollander JE. Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Acad. Emerg. Med. 13(1), 13–18 (2006).